LHC Group

LHC — Q4 2021 Earnings Presentation

52 slides from LHC's earnings presentation, Feb 24, 2022

  1. Slide 1: Supplemental Financial Information Fourth Quarter Ended December 31, 2021

    Supplemental Financial Information Fourth Quarter Ended December 31, 2021 February 23, 2022 1 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company. Words such as “anticipate,” “expect,” “project,” “intend,”

  3. Slide 3: Table of Contents

    Full Year 2022 Guidance First Quarter 2022 Guidance Bridge from Q4 2021 to Q2 2022 Bridge from Q4 2021 to 1H 2022 2H 2022 Assumptions Home Health Trend Home Health Census vs. Clinician Quarantine Hospice Census vs. Clinician Quarantine Debt and Liquidity Metrics Focus for 2022 TABLE OF CONTENTS Busi

  4. Slide 4: Business & Legislative Overview

    BUSINESS & LEGISLATIVE OVERVIEW 4

  5. Slide 5: LHC Group Overview

    Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC GROUP OVERVIEW LEGEND: 557 home health locations 170 hospice locations 136 home & community based services locations 12 long term acute care hospital locations 95 other service locations 435 leading ho

  6. Slide 6: Commentary on Q4 2021

    Higher labor costs and capacity constraints caused by the lingering impact of clinicians on quarantine caused significant headwinds for Q4 2021. The percentage of clinicians on quarantine increased to 3.5% at the end of the fourth quarter of 2021, up from 3.0% at the end of the third quarter. The el

  7. Slide 7: Commentary on Q4 2021 and FY 2021

    Momentum from new physician referral sources continued with 4,578 new and unique home health referral sources added in Q4 which is a 9.2% increase over the same period in 2020. For 2021, 19,948 new and unique home health referral sources were added, 19.6% higher than 2020. Home Health average daily

  8. Slide 8: Favorable Legislation and Policies on Home Care

    Choose Home Care Act of 2021 allows Medicare seniors to choose to recover at home as opposed to an in-patient healthcare facility after a hospitalization and who meet the eligibility for Skilled Nursing Facility (SNF). Senate bill (S-2562) has bipartisan support and now 18 co-sponsors from both part

  9. Slide 9: The Better Care Better Jobs Act

    The Better Care Better Jobs Act: Senators Casey (D-PA), Wyden (D-OR), Schumer (D-NY), Murray (D-WA), Duckworth (D-IL), Hassan (D-NH) and Brown (D-OH) are introducing the Better Care Better Jobs Act, a key element of President Biden’s American Jobs Plan. Representatives Dingell (D-MI-12), Pallone (D-

  10. Slide 10: Unprecedented Support for Home Care

    UNPRECEDENTED SUPPORT FOR HOME CARE 10 Adults prefer to recover at home after a hospital stay* 86% of adults and 94% of Medicare beneficiaries say they would prefer to receive post-hospital short-term health care at home Expanding home recovery options should be a government priority* 85% of adults,

  11. Slide 11: Differentiated Strategies

    DIFFERENTIATED STRATEGIES 11

  12. Slide 12: Differentiated Strategy Leading to Quality Growth

    Joint ventures drive organic growth and margin improvement Same store growth for JV locations average between 200 and 300 basis points higher than non-JV locations. Revenue growth rate for JVs average 10% to 15% in year 2 and 3. Margins for JV locations average 100 to 200 basis points higher than no

  13. Slide 13: Differentiated Strategy Leading to Quality Growth Continued

    Continued focus on quality and patient satisfaction to drive higher referrals Increased new home health physician referral sources by 22.0% in 2020 over 2019; by 19.1% in 2021 compared to 2020 and by 9.2% in Q4 of 2021. Untapped growth in home health and hospice co-locations remains top priority 86

  14. Slide 14: Multiple Organic and Inorganic Growth Levers

    MULTIPLE ORGANIC AND INORGANIC GROWTH LEVERS Organic Growth Acquisition Growth Upside Opportunities Move to taking risk on total cost of HH from MA plans and health systems Grow Imperium ACOs and extend proven record of managing post-acute network building Create high performing post-acute networks

  15. Slide 15: Building Blocks of Long-Term Earnings Growth

    BUILDING BLOCKS OF LONG-TERM EARNINGS GROWTH Developing alternative reimbursement models (PMPM; Case Rate; episodic) with regional and national payors, demonstrating continued progression beyond fee-for-service and per visit relationships Revising contracts and developing processes with major payors

  16. Slide 16: Full Time Clinical Staff Hires

    FULL TIME CLINICAL STAFF HIRES 16 We continue to see positive trends in recruiting. We have four consecutive quarters in which we have hired a record number of employees while our turnover continues to be well below industry averages. Our headcount statistics are a direct correlation and validation

  17. Slide 17: Sequential Operational Trends

    SEQUENTIAL OPERATIONAL TRENDS Home Health, Hospice, and HCBS Trends 17

  18. Slide 18: Home Health and Hospice Clinicians on Quarantine Trend

    HOME HEALTH AND HOSPICE CLINICIANS ON QUARANTINE TREND 18

  19. Slide 19: Home Health Labor Cost per Visit

    HOME HEALTH LABOR COST PER VISIT 19

  20. Slide 20: Home Health and Hospice Growth

    HOME HEALTH AND HOSPICE GROWTH Same Store Organic Admission Growth over Prior-Year Periods New Physician Home Health Referral Sources 20 Q1 2021 Q2 2021 Q3 2021 Q4 2021 FY 2021 Q1 2022 Pacing Home Health - 0.4% 16.4% 3.6% 3.8% 5.5% 5% to 7% Hospice 7.6% 1.1% 0.1% - 6.2% 0.5% 8% to 10%Q1 2021 Q2 2021

  21. Slide 21: Industry-Leading Quality and Patient Satisfaction

    INDUSTRY-LEADING QUALITY AND PATIENT SATISFACTION 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approximately 15% of all Medicare certified home health agencies nationwide are Joint Com

  22. Slide 22: 2021 M&A Activity Sets the Stage for 2022 Growth

    2021 M&A ACTIVITY SETS THE STAGE FOR 2022 GROWTH The acquired annual revenue of approximately $300 million for 2021 is expected to have an incremental impact to 2022 of approximately $200 million in revenue and approximately $20 million in EBITDA. 22 Acquisition/Joint Venture Partner State Date Clos

  23. Slide 23: 2021 Consolidated Results

    2021 CONSOLIDATED RESULTS 23

  24. Slide 24: 2021 Adjusted Consolidated Results

    2021 ADJUSTED CONSOLIDATED RESULTS 24 Three months ended December 31 Twelve months ended December 31 Consolidated Total Adjustments Adjusted Consolidated Consolidated Total Adjustments Adjusted Consolidated Net service revenue $583,429 $0 $583,429 $2,219,622 $0 $2,219,622 Cost of service revenue 364

  25. Slide 25: Adjusted Consolidated Results – 2021 vs 2020

    ADJUSTED CONSOLIDATED RESULTS – 2021 VS 2020 25 Three months ended December 31, Twelve months ended December 31, 2021 Adjusted Consolidated % of rev 2020 Adjusted Consolidated % of rev 2021 Adjusted Consolidated % of rev 2020 Adjusted Consolidated % of rev Net service revenue $583,429 $532,329 $2,21

  26. Slide 26: Adjustments to Net Income

    ADJUSTMENTS TO NET INCOME 26 *See footnotes on page 27 PRE TAX ADJUSTMENTS Q4 2021 Q4 2020 2021 2020 Acquisition, de novo and legal expenses ( $10,082 $3,214 $24,154 $7,770 Closures/relocations/consolidations ( 412 4,019 2,510 5,193 COVID 19 PPE, supplies and other expenses ( 14,826 12,159 51,661 52

  27. Slide 27: Adjustments to Net Income Continued

    ADJUSTMENTS TO NET INCOME CONTINUED Expenses and other costs associated with recently announced or completed acquisitions, de novos and legal expenses ($10.1 million and $24.2 million pre-tax in the three months and year ended December 31, 2021, respectively; $3.2 million and $7.8 million pre-tax in

  28. Slide 28: Segment Results

    SEGMENT RESULTS 28

  29. Slide 29: Three Months Ended Dec. 31, 2021 Adjusted Segment Results

    THREE MONTHS ENDED DEC. 31, 2021 ADJUSTED SEGMENT RESULTS 29 Home health services Adjustments Adjusted Home health services Hospice services Adjustments Adjusted Hospice services HCBS services Adjustments Adjusted HCBS services Net service revenue $394,481 $394,481 $102,027 $102,027 $46,229 $46,229

  30. Slide 30: Year Ended Dec. 31, 2021 Adjusted Segment Results

    YEAR ENDED DEC. 31, 2021 ADJUSTED SEGMENT RESULTS 30 Home health services Adjustments Adjusted Home health services Hospice services Adjustments Adjusted Hospice services HCBS services Adjustments Adjusted HCBS services Net service revenue $1,551,542 $0 $1,551,542 $311,218 $0 $311,218 $189,561 $0 $1

  31. Slide 31: Home Health Segment Adjusted Results – 2021 vs 2020

    HOME HEALTH SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 31 For the three months ended December 31, 2021, Revenue increased by $11.8 million or 3.1% as compared to Q4 2020. The increase in revenue is due to approximately $9.4 million of inorganic revenue from the HCA/Brookdale acquisition, an app

  32. Slide 32: Hospice Segment Adjusted Results – 2021 vs 2020

    HOSPICE SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 32 For the three months ended December 31, 2021, revenue increased $39.6 million. The increase in revenue is due to approximately $38.8 million of inorganic revenue from recent acquisitions and approximately $2 million from same store growth of

  33. Slide 33: Home and Community Based Services Segment Results – 2021 vs 2020

    HOME AND COMMUNITY BASED SERVICES SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 33 For the three months ended December 31, 2021, revenue decreased $3.8 million or -7.6% as compared to Q4 2020. The decrease in revenue is due to a 5.6% decline in billable hours owing to ongoing staffing constraints

  34. Slide 34: Facility-Based Services Segment Results – 2021 vs 2020

    FACILITY-BASED SERVICES SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 34 For the three months ended December 31, 2021, Revenue increased by $3.4 million or 10.6% as compared to Q4 2020. The increase in revenue is due to approximately $3 million of inorganic revenue from the recent acquisition of t

  35. Slide 35: Health Care Innovations Segment Results – 2021 vs 2020

    HEALTH CARE INNOVATIONS SEGMENT ADJUSTED SEGMENT RESULTS – 2021 VS 2020 35 Three months ended December 31, Twelve months ended December 31, 2021 Adjusted HCI services % of rev 2020 Adjusted HCI services % of rev 2021 Adjusted HCI services % of rev 2020 Adjusted HCI services % of rev Net service reve

  36. Slide 36: Guidance, Liquidity & Outlook

    GUIDANCE, LIQUIDITY & OUTLOOK 36

  37. Slide 37: Full Year 2022 Guidance

    Assumptions: 5% to 7% organic growth in home health admissions for the year; 6% to 8% organic growth in hospice admissions for the year. Gross margin as a percent of revenue range 40% to 41%. General and administrative expense as a percent of revenue range 28% to 29%. Estimated interest expense of $

  38. Slide 38: Full Year 2022 Guidance Continued

    FULL YEAR 2022 GUIDANCE CONTINUED 38 NSR $ EBITDA $ EBITDA % 2021 BASELINE $2,219.6 $265.5 12.0% 2022 DEVELOPMENTS: SEQUESTRATION ($16.0) ($16.0) COVID SPEND ($30.0) HIGHER LABOR COST ($26.5) HOME HEALTH RATE INCREASE $25.0 $25.0 HOSPICE RATE INCREASE $7.0 $7.0 ORGANIC GROWTH $90.0 $10.0 INCREMENTAL

  39. Slide 39: First Quarter 2022 Guidance

    FIRST QUARTER 2022 GUIDANCE (SEE BRIDGE ON SLIDE 40) 39 Low Midpoint High Revenue $560 million $570 million $580 million Adjusted EPS $1.00 $1.05 $1.10 Adjusted EBITDA less NCI $50 million $52.5 million $55 million

  40. Slide 40: Bridge from Q4 2021 to Q2 2022

    BRIDGE FROM Q4 2021 TO Q2 2022 (SEE ASSUMPTIONS ON SLIDE 41) 40

  41. Slide 41: Bridge from Q4 2021 to 1H 2022

    BRIDGE FROM Q4 2021 TO 1H 2022 41 Bridge Growth Assumptions from Q1 2022 to Q2 2022 Home Health average census assumed for the first quarter of 2022 is approximately 86,500. Home Health average census to achieve the second quarter of 2022 bridge growth is approximately 88,900. On February 21, 2022,

  42. Slide 42: 2H 2022 Assumptions

    2H 2022 ASSUMPTIONS 42 Bridge from 1st half of 2022 to 2nd half of 2022 Improvement in contribution margin from 2021 acquisitions COVID spend improvement Improvement in contract labor utilization Assumes 1% utilization improvement in Q2 and in Q3. Every 1% improvement in utilization equates to $1.4

  43. Slide 43: Oct 2021 – Feb 2022 Home Health Trend

    OCT 2021 – FEB 2022 HOME HEALTH TREND 43 Home Health average weekly census declined to a low 83,061 during the week ended January 15, 2022 as the average percentage of clinicians quarantined increased to 6.04% for the week ending January 15th, exacerbating the normal seasonal dip in January. Home He

  44. Slide 44: Home Health Census versus Clinician Quarantine Correlation

    OCT 2021 – FEB 2022 HOME HEALTH CENSUS VERSUS CLINICIAN QUARANTINE CORRELATION 44

  45. Slide 45: Hospice Census versus Clinician Quarantine Correlation

    OCT 2021 – FEB 2022 HOSPICE CENSUS VERSUS CLINICIAN QUARANTINE CORRELATION 45

  46. Slide 46: Debt and Liquidity Metrics

    DEBT AND LIQUIDITY METRICS 46 Outstanding Debt ( amounts in thousands As of Dec. 31, 2021 Total Debt Balance Sheet $661,197 Less: Cash $9,809 Net Debt $651,388 Net debt to estimated TTM adjusted EBITDA ratio 2.5x Credit Facility amounts in thousands As of Dec. 31, 2021 Revolver Size $1,000,000 Less:

  47. Slide 47: Focus for 2022

    FOCUS FOR 2022 47 Maintain disciplined capital allocation with new joint ventures and other M&A activity. Accelerate unlocking the potential of our co-location and tri-location strategies. Continue to be a leader in the industry in quality and patient satisfaction scores. Capture market share gains

  48. Slide 48: Appendix

    APPENDIX 48

  49. Slide 49: Non-GAAP Reconciliations

    NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) 49 *Footnotes are on page 51 RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP Three Months Ended Dec 31, Three Months Ended Dec 31, Twelve Months Ended Dec 31, Twelve Months Ended Dec 31, 2021 2020 2021 2020 Net income attribu

  50. Slide 50: Non-GAAP Reconciliations

    NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) *Footnotes are on page 51 50 RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP PER DILUTED SHARE Three Months Ended Dec 31, Three Months Ended Dec 31, Twelve Months Ended Dec 31, Twelve Months Ended Dec 31, 2021 2020 2021 2020

  51. Slide 51: Non-GAAP Reconciliations: Adjusted EBITDA

    NON-GAAP RECONCILIATIONS (AMOUNTS IN THOUSANDS, UNAUDITED) Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) 51 Expenses and other costs associated with recently announced or completed acquisitions, de novos and legal expenses ($10.1 million and $24.2 million

  52. Slide 52: It all about helping people.

    It all about helping people.

LHC Group — Q4 2021 Earnings Presentation on 6ix